1. Home
  2. HCM vs APAM Comparison

HCM vs APAM Comparison

Compare HCM & APAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • APAM
  • Stock Information
  • Founded
  • HCM 2000
  • APAM 1994
  • Country
  • HCM Hong Kong
  • APAM United States
  • Employees
  • HCM N/A
  • APAM N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • APAM Investment Managers
  • Sector
  • HCM Health Care
  • APAM Finance
  • Exchange
  • HCM Nasdaq
  • APAM Nasdaq
  • Market Cap
  • HCM 2.6B
  • APAM 3.0B
  • IPO Year
  • HCM N/A
  • APAM 2013
  • Fundamental
  • Price
  • HCM $15.30
  • APAM $44.42
  • Analyst Decision
  • HCM Sell
  • APAM Buy
  • Analyst Count
  • HCM 1
  • APAM 4
  • Target Price
  • HCM $13.75
  • APAM $47.00
  • AVG Volume (30 Days)
  • HCM 34.7K
  • APAM 403.9K
  • Earning Date
  • HCM 08-07-2025
  • APAM 10-28-2025
  • Dividend Yield
  • HCM N/A
  • APAM 8.16%
  • EPS Growth
  • HCM N/A
  • APAM 2.95
  • EPS
  • HCM 0.53
  • APAM 3.71
  • Revenue
  • HCM $602,197,000.00
  • APAM $1,158,234,000.00
  • Revenue This Year
  • HCM N/A
  • APAM $8.74
  • Revenue Next Year
  • HCM $15.49
  • APAM $7.94
  • P/E Ratio
  • HCM $5.70
  • APAM $12.00
  • Revenue Growth
  • HCM N/A
  • APAM 8.88
  • 52 Week Low
  • HCM $11.51
  • APAM $32.75
  • 52 Week High
  • HCM $19.50
  • APAM $49.54
  • Technical
  • Relative Strength Index (RSI)
  • HCM 49.84
  • APAM 50.76
  • Support Level
  • HCM $14.40
  • APAM $42.78
  • Resistance Level
  • HCM $15.36
  • APAM $45.52
  • Average True Range (ATR)
  • HCM 0.33
  • APAM 1.06
  • MACD
  • HCM 0.07
  • APAM 0.15
  • Stochastic Oscillator
  • HCM 64.84
  • APAM 55.77

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.

Share on Social Networks: